Literature DB >> 35771446

In Vivo Analysis of Mitochondrial Protein Synthesis in Saccharomyces cerevisiae Mitochondrial tRNA Mutants.

Arianna Montanari1.   

Abstract

I describe here a protocol for the analysis of mitochondrial protein synthesis as a useful tool to characterize the mitochondrial defects associated with mutations in mitochondrial tRNA genes. The yeast Saccharomyces cerevisiae mutants, bearing human equivalent pathogenic mutations, were used as a simple model for analysis. The mitochondrial proteins were labeled by L[35S]-methionine incorporation in growing cells, extracted from purified mitochondria, and fractionated by SDS-polyacrylamide gel electrophoresis followed by autoradiography. By this method, it is possible to distinguish different protein synthesis profiles in the analyzed mitochondrial tRNA mutants.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Human equivalent mutations; In vivo L[35S]-methionine labeling; Mitochondria; Mitochondrial protein synthesis; Mitochondrial tRNA mutants; Saccharomyces cerevisiae

Mesh:

Substances:

Year:  2022        PMID: 35771446     DOI: 10.1007/978-1-0716-2309-1_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Aminoacyl-tRNA synthetases are multivalent suppressors of defects due to human equivalent mutations in yeast mt tRNA genes.

Authors:  Arianna Montanari; Cristina De Luca; Laura Frontali; Silvia Francisci
Journal:  Biochim Biophys Acta       Date:  2010-05-13

2.  Can yeast be used to study mitochondrial diseases? Biolistic tRNA mutants for the analysis of mechanisms and suppressors.

Authors:  Cristina De Luca; YouFang Zhou; Arianna Montanari; Veronica Morea; Romina Oliva; Celine Besagni; Monique Bolotin-Fukuhara; Laura Frontali; Silvia Francisci
Journal:  Mitochondrion       Date:  2009-07-23       Impact factor: 4.160

3.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

4.  Plasmids can stably transform yeast mitochondria lacking endogenous mtDNA.

Authors:  T D Fox; J C Sanford; T W McMullin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Yeast as a model of human mitochondrial tRNA base substitutions: investigation of the molecular basis of respiratory defects.

Authors:  Arianna Montanari; Céline Besagni; Cristina De Luca; Veronica Morea; Romina Oliva; Anna Tramontano; Monique Bolotin-Fukuhara; Laura Frontali; Silvia Francisci
Journal:  RNA       Date:  2007-12-07       Impact factor: 4.942

Review 6.  Mitochondrial Diseases: Hope for the Future.

Authors:  Oliver M Russell; Gráinne S Gorman; Robert N Lightowlers; Doug M Turnbull
Journal:  Cell       Date:  2020-03-26       Impact factor: 41.582

7.  The yeast counterparts of human 'MELAS' mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF-Tu.

Authors:  M Feuermann; S Francisci; T Rinaldi; C De Luca; H Rohou; L Frontali; M Bolotin-Fukuhara
Journal:  EMBO Rep       Date:  2003-01       Impact factor: 8.807

8.  Aminoacylation and conformational properties of yeast mitochondrial tRNA mutants with respiratory deficiency.

Authors:  Silvia Francisci; Cristina DE Luca; Romina Oliva; Veronica Morea; Anna Tramontano; Laura Frontali
Journal:  RNA       Date:  2005-06       Impact factor: 4.942

9.  Structural and functional role of bases 32 and 33 in the anticodon loop of yeast mitochondrial tRNAIle.

Authors:  Arianna Montanari; Cristina De Luca; Patrizio Di Micco; Veronica Morea; Laura Frontali; Silvia Francisci
Journal:  RNA       Date:  2011-09-13       Impact factor: 4.942

10.  Mutations in yeast mt tRNAs: specific and general suppression by nuclear encoded tRNA interactors.

Authors:  C De Luca; C Besagni; L Frontali; M Bolotin-Fukuhara; S Francisci
Journal:  Gene       Date:  2006-04-29       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.